RA Capital Management Q3 2022 holdings

$4.69 Billion is the total value of RA Capital Management's 81 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 37.5% .

 Value Shares↓ Weighting
ASND  ASCENDIS PHARMA A/Ssponsored adr$781,462
+11.1%
7,567,9000.0%16.67%
-11.1%
BIIB BuyBIOGEN INC$250,325
+68.8%
937,549
+29.0%
5.34%
+35.1%
 CYTEK BIOSCIENCES INC$196,969
+37.2%
13,381,0540.0%4.20%
+9.8%
FMTX  FORMA THERAPEUTICS HLDGS INC$179,782
+189.6%
9,011,6510.0%3.84%
+131.7%
DAWN  DAY ONE BIOPHARMACEUTICALS I$141,024
+11.9%
7,040,6220.0%3.01%
-10.5%
AVTE  AEROVATE THERAPEUTICS INC$137,017
+6.1%
8,263,9820.0%2.92%
-15.1%
RYTM BuyRHYTHM PHARMACEUTICALS INC$134,041
+563.1%
5,471,067
+12.3%
2.86%
+430.6%
TVTX  TRAVERE THERAPEUTICS INC$121,301
+1.7%
4,922,9410.0%2.59%
-18.6%
BLU BuyBELLUS HEALTH INC NEW$120,232
+27.2%
11,385,574
+11.3%
2.56%
+1.8%
JANX  JANUX THERAPEUTICS INC$117,401
+10.9%
8,670,6440.0%2.50%
-11.3%
PCVX  VAXCYTE INC$109,949
+10.3%
4,581,2030.0%2.35%
-11.7%
 DICE THERAPEUTICS INC$105,637
+30.7%
5,208,9110.0%2.25%
+4.6%
IMGN  IMMUNOGEN INC$103,924
+6.2%
21,741,4580.0%2.22%
-15.0%
NKTX  NKARTA INC$102,716
+6.8%
7,805,1290.0%2.19%
-14.5%
ABOS  ACUMEN PHARMACEUTICALS INC$98,001
+113.4%
9,770,7730.0%2.09%
+70.8%
LEGN NewLEGEND BIOTECH CORPsponsored ads$95,4152,338,610
+100.0%
2.04%
ITOS  ITEOS THERAPEUTICS INC$84,149
-7.5%
4,417,2590.0%1.80%
-26.0%
RLMD  RELMADA THERAPEUTICS INC$74,040
+94.9%
2,000,0000.0%1.58%
+56.0%
 PEPGEN INC$73,838
-8.6%
8,131,9520.0%1.58%
-26.8%
GERN  GERON CORP$70,496
+51.0%
30,126,2990.0%1.50%
+20.8%
ACRS  ACLARIS THERAPEUTICS INC$69,231
+12.7%
4,398,4530.0%1.48%
-9.8%
NewTHIRD HARMONIC BIO INC$65,9343,475,687
+100.0%
1.41%
BuyAN2 THERAPEUTICS INC$65,584
+125.8%
3,773,517
+0.7%
1.40%
+80.5%
 TYRA BIOSCIENCES INC$63,609
+22.9%
7,236,4540.0%1.36%
-1.7%
WVE  WAVE LIFE SCIENCES LTD$62,099
+11.1%
17,202,0090.0%1.32%
-11.1%
VRNA BuyVERONA PHARMA PLCsponsored ads$61,831
+189.3%
6,050,000
+18.6%
1.32%
+131.4%
COGT NewCOGENT COMMUNICATIONS HLDGS$59,8814,013,453
+100.0%
1.28%
NSTG BuyNANOSTRING TECHNOLOGIES$58,774
+29.1%
4,602,478
+28.4%
1.25%
+3.3%
CLDX  CELLDEX THERAPEUTICS INC NEW$58,328
+4.3%
2,075,0000.0%1.24%
-16.6%
GHRS  GH RESEARCH PLCordinary shares$56,919
+16.4%
4,898,3730.0%1.21%
-6.8%
FULC NewFULCRUM THERAPEUTICS INC$56,6307,000,000
+100.0%
1.21%
KNTE  KINNATE BIOPHARMA INC$50,956
-5.2%
4,264,1440.0%1.09%
-24.2%
ENTA  ENANTA PHARMACEUTICALS INC$46,513
+9.7%
896,7240.0%0.99%
-12.2%
DSGN BuyDESIGN THERAPEUTICS INC$46,368
+51.5%
2,773,231
+26.8%
0.99%
+21.2%
ETNB  89BIO INC$45,062
+79.8%
7,782,6690.0%0.96%
+43.9%
VOR  VOR BIOPHARMA INC$44,261
-19.9%
11,120,9730.0%0.94%
-36.0%
 ELIEM THERAPEUTICS INC$42,477
+7.0%
13,150,8490.0%0.91%
-14.4%
TIL  INSTIL BIO INC$37,127
+4.8%
7,670,7930.0%0.79%
-16.2%
 RXSIGHT INC$36,633
-14.8%
3,052,7960.0%0.78%
-31.8%
STSA  SATSUMA PHARMACEUTICALS INC$35,486
+44.9%
5,914,2520.0%0.76%
+15.9%
RNA  AVIDITY BIOSCIENCES INC$35,393
+12.4%
2,167,3910.0%0.76%
-10.1%
VERA  VERA THERAPEUTICS INCcl a$33,645
+56.6%
1,578,8200.0%0.72%
+25.3%
RCKT  ROCKET PHARMACEUTICALS INC$33,630
+16.0%
2,107,1490.0%0.72%
-7.2%
AKRO NewAKERO THERAPEUTICS INC$32,653958,980
+100.0%
0.70%
ALPN NewALPINE IMMUNE SCIENCES INC$31,3684,356,632
+100.0%
0.67%
 HILLEVAX INC$30,079
+56.4%
1,760,0190.0%0.64%
+25.1%
ACET NewADICET BIO INC$29,2842,059,372
+100.0%
0.62%
EYPT  EYEPOINT PHARMACEUTICALS INC$26,660
+0.5%
3,370,5060.0%0.57%
-19.5%
MIST  MILESTONE PHARMACEUTICALS IN$20,645
+49.4%
2,246,5030.0%0.44%
+19.6%
PMVP  PMV PHARMACEUTICALS INC$20,352
-16.5%
1,710,2650.0%0.43%
-33.2%
HOWL  WEREWOLF THERAPEUTICS INC$19,356
+10.3%
4,291,8810.0%0.41%
-11.8%
 ICOSAVAX INC$18,845
-44.9%
5,963,5650.0%0.40%
-55.9%
VRDN NewVIRIDIAN THERAPEUTICS INCsponsored ads$18,049880,000
+100.0%
0.38%
RLAY BuyRELAY THERAPEUTICS INC$16,053
+74.5%
717,618
+30.7%
0.34%
+39.6%
 DA32 LIFE SCNCE$14,595
+0.4%
1,500,0000.0%0.31%
-19.8%
BLSA  BCLS ACQUISITION CORP$12,525
+1.2%
1,250,0000.0%0.27%
-19.1%
 PARDES BIOSCIENCES INC$11,424
-39.7%
6,175,0380.0%0.24%
-51.7%
ACHL  ACHILLES THERAPEUTICS PLCsponsored ads$11,333
-10.3%
5,014,6870.0%0.24%
-28.2%
FLACU  FRAZIER LIFESCIENCES ACQU CO$9,980
+1.1%
1,000,0000.0%0.21%
-19.0%
 ARYA SCIENCES ACQUISITN CORP$9,800
+0.8%
1,000,0000.0%0.21%
-19.3%
CNTB  CONNECT BIOPHARMA HLDGS LTDads$9,018
+48.3%
6,991,0030.0%0.19%
+18.5%
BuyAADI BIOSCIENCE INC$8,340
+76.7%
590,218
+54.1%
0.18%
+41.3%
FVAM  5 01 ACQUISITION CORP$7,500
+1.0%
750,0000.0%0.16%
-19.2%
CNCE SellCONCERT PHARMACEUTICALS INC$7,292
-47.6%
1,088,296
-67.1%
0.16%
-58.0%
DBVT NewDBV TECHNOLOGIES S Asponsored adr$6,5933,724,740
+100.0%
0.14%
HSAQ SellHEALTH SCIENCES ACQ CORP 2$6,042
-2.9%
610,283
-2.4%
0.13%
-22.3%
SLDB  SOLID BIOSCIENCES INC$5,771
-24.2%
12,367,8730.0%0.12%
-39.4%
ATHA  ATHIRA PHARMA INC$5,578
-2.6%
1,878,0000.0%0.12%
-22.2%
MGTA NewMAGENTA THERAPEUTICS INC$5,0593,588,081
+100.0%
0.11%
 IO BIOTECH INC$5,035
-42.0%
1,857,7550.0%0.11%
-53.7%
SellTENAYA THERAPEUTICS INC$4,646
-76.8%
1,602,009
-54.9%
0.10%
-81.4%
SYBX SellSYNLOGIC INC$4,387
-34.5%
4,618,415
-20.7%
0.09%
-47.5%
BDTX  BLACK DIAMOND THERAPEUTICS I$4,377
-31.3%
2,589,9040.0%0.09%
-45.3%
CVRX  CVRX INC$2,566
+55.2%
275,0000.0%0.06%
+25.0%
ENTX SellENTERA BIO LTD$2,166
-30.8%
2,082,372
-11.5%
0.05%
-44.6%
FUSN NewFUSION PHARMACEUTICALS INC$1,987659,992
+100.0%
0.04%
SellPYXIS ONCOLOGY INC$1,506
-33.6%
764,653
-19.8%
0.03%
-46.7%
SNSE SellSENSEI BIOTHERAPEUTICS$1,059
-35.5%
683,529
-5.5%
0.02%
-47.7%
BOLT BuyBOLT BIOTHERAPEUTICS INC$789
-14.1%
533,432
+18.5%
0.02%
-29.2%
APTX NewAPTINYX INC$7201,954,698
+100.0%
0.02%
AGLE NewAEGLEA BIOTHERAPEUTICS INC$510,439
+100.0%
0.00%
CLBS ExitCALADRIUS BIOSCIENCES$0-752,500
-100.0%
-0.01%
AVRO ExitAVROBIO INC$0-559,600
-100.0%
-0.01%
OLMA ExitOLEMA PHARMACEUTICALS INC$0-233,793
-100.0%
-0.02%
ORTX ExitORCHARD THERAPEUTICS PLCads$0-3,040,885
-100.0%
-0.05%
LRMR ExitLARIMAR THERAPEUTICS INC$0-1,031,482
-100.0%
-0.05%
ADVM ExitADVERUM BIOTECHNOLOGIES INC$0-1,726,019
-100.0%
-0.06%
ExitASTRIA THERAPEUTICS INC$0-760,857
-100.0%
-0.06%
BCAB ExitBIOATLA INC$0-1,031,805
-100.0%
-0.08%
TERN ExitTERNS PHARMACEUTICALS INC$0-1,261,435
-100.0%
-0.08%
FLDM ExitSTANDARD BIOTOOLS INC$0-1,987,589
-100.0%
-0.08%
ExitXILIO THERAPEUTICS INC$0-1,649,711
-100.0%
-0.13%
BMEA ExitBIOMEA FUSION INC$0-500,000
-100.0%
-0.16%
IPSC ExitCENTURY THERAPEUTICS INC$0-756,821
-100.0%
-0.17%
ExitLIANBIOsponsored ads$0-4,622,574
-100.0%
-0.27%
OTIC ExitOTONOMY INC$0-5,600,000
-100.0%
-0.31%
GH ExitGUARDANT HEALTH INC$0-476,380
-100.0%
-0.51%
DYN ExitDYNE THERAPEUTICS INC$0-2,805,045
-100.0%
-0.51%
NTRA ExitNATERA INC$0-1,310,289
-100.0%
-1.24%
PNT ExitPOINT BIOPHARMA GLOBAL INC$0-9,003,018
-100.0%
-1.64%
VERU ExitVERU INC$0-7,900,000
-100.0%
-2.38%

The following EDGAR filing(s) were analyzed to create this report:

The EDGAR filing(s) were signed by:

  • Rajeev Shah — Authorized Signatory

Compare quarterly holdings

Export RA Capital Management's holdings

EDGAR filings